CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Major trials in coronary intervention from 2018 Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States

Expert Opinion2018 Nov 3. [Epub ahead of print]

JOURNAL:J Am Coll Cardiol. Article Link

Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Special Report From the American Heart Association and American College of Cardiology

Lloyd-Jones DM, Braun LT, Ndumele CE et al. Keywords: prevention; AHA Scientific Statements; risk assessment; secondary prevention; primary prevention; relative risk; atherosclerotic cardiovascular disease

FULL TEXT PDF